Personalized Antibodies For Gastroesophageal Adenocarcinoma (Pangea): Primary Efficacy Analysis Of The Phase Ii Platform Trial (Nct02213289)
JOURNAL OF CLINICAL ONCOLOGY(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2020)